Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

Computational evaluation of the inhibitory potential of some urea, thiourea, and selenourea derivatives of diselenides against leishmaniasis: 2D-QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation
Fabian Audu Ugbe, Emmanuel Israel Edache, Shola Elijah Adeniji, et al.
Journal of Molecular Structure (2024) Vol. 1302, pp. 137473-137473
Closed Access | Times Cited: 13
Cheminformatics-based discovery of new organoselenium compounds with potential for the treatment of cutaneous and visceral leishmaniasis
Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-24
Closed Access | Times Cited: 19
Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors
Andrey Kovalevsky, Annie Aniana, Leighton Coates, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 7, pp. 104886-104886
Open Access | Times Cited: 18
An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents
Mohamed El fadili, Mohammed Er-rajy, Wafa Ali Eltayb, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6174-6188
Closed Access | Times Cited: 17
Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus
Amgad M. Rabie, Marwa A. Abdel-Dayem, Mohnad Abdalla
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35538-35554
Open Access | Times Cited: 17
In-silico design of a new multi-epitope vaccine candidate against SARS-CoV-2
Abbas Alibakhshi, Armina Alagheband Bahrami, Elmira Mohammadi, et al.
Acta Virologica (2024) Vol. 67
Open Access | Times Cited: 6
Future of the current anticoronaviral agents: A viewpoint on the validation for the next COVIDs and pandemics
Amgad M. Rabie
Biocell (2023) Vol. 47, Iss. 10, pp. 2133-2139
Open Access | Times Cited: 16
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies
Yasser Hussein Eissa Mohammed, Israa M. Shamkh, Nahed S. Alharthi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Green synthesis of bio-mediated silver nanoparticles from Persea americana peels extract and evaluation of their biological activities: In vitro and in silico insights
M. Ali, A.S. Mahmoud, Mohnad Abdalla, et al.
Journal of Saudi Chemical Society (2024) Vol. 28, Iss. 3, pp. 101863-101863
Open Access | Times Cited: 5
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds
M. Tariq Nazir, Matloob Ahmad, Sana Aslam, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1547-1571
Open Access | Times Cited: 5
Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials
Ke‐Wei Zhu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
Kiran Shehzadi, Afsheen Saba, Mingjia Yu, et al.
Topics in Current Chemistry (2023) Vol. 381, Iss. 5
Closed Access | Times Cited: 11
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro
Jiayi Ren, Zhengfu Zhang, Yi Xia, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 351-351
Open Access
Docking and Post-Processing of 1 Million Molecules from the CNCL Database in Search of SARS-CoV-2 Mpro Inhibitors
А.В. Сулимов, Danil Kutov, Ivan Ilin, et al.
Lecture notes in computer science (2025), pp. 47-58
Closed Access
Insight Study For Repurposing Of Certain Anti‐Inflammatory Drugs Based On Aspirin and Salicylic Acid Scaffolds For The Treatment of Cancer as CDKs Inhibitors: Cheminformatics and Anticancer Studies
Mohnad Abdalla, Ahmed E. Elmasry, Mohamed T. M. Nemr, et al.
ChemistrySelect (2025) Vol. 10, Iss. 15
Closed Access
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
Larysa V. Yevsieieva, Kateryna Lohachova, Alexander Kyrychenko, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35500-35524
Open Access | Times Cited: 10
The Isoquinoline Derivative "CYNOVID" as a Prospective Anti-SARS-CoV-2 Agent: An Expanded Investigative Computational Study
Amgad M. Rabie, Imane Yamari, Samir Chtita
European Journal of Medicinal Chemistry Reports (2024), pp. 100214-100214
Open Access | Times Cited: 3
Phytochemical-based drug designing against efflux-pump of ESKAPE pathogen to combat multidrug-resistant: an in silico study
Anshika Gupta, Akriti Verma, Kalpana Katiyar
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-21
Closed Access
COVID-19: An Update on the Latest Therapeutic Agents
Ke-Yan Loo, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Comprehensive bioinformatics analysis of structural and functional consequences of deleterious missense mutations in the human QDPR gene
Aishwarya Girish, Samruddhi Sutar, T. P. Krishna Murthy, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5485-5501
Closed Access | Times Cited: 8
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles
Valentina Di Salvatore, Elena Crispino, Avisa Maleki, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3339-3354
Open Access | Times Cited: 7
RNA-targeted small-molecule drug discoveries: a machine-learning perspective
Huan Xiao, Xin Yang, Yihao Zhang, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 384-397
Open Access | Times Cited: 7
Discovery of Hybrid Thiouracil–Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus’s Polymerase “RdRp” as a Confirmed Interacting Biomolecule
Divakar Vishwanath, Anita M. Shete, Manjunath B. Honnegowda, et al.
ACS Omega (2023) Vol. 8, Iss. 30, pp. 27056-27066
Open Access | Times Cited: 7
Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
Viviana De Luca, Andrea Angeli, Alessio Nocentini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 971-971
Open Access | Times Cited: 2
Application and Development of Targeted Fishing Technology in Natural Product Screening - A Simple Minireview
Yingying Su, Weiping Wang, Ying Wang, et al.
Current Pharmaceutical Analysis (2024) Vol. 20, Iss. 4, pp. 231-240
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top